Jonas Bergquist

Jonas Bergquist, MD – PhD, is a Full Chair Professor in Analytical Chemistry and Neurochemistry at the Biomedical Centre, Department of Chemistry at Uppsala University, Sweden, Adjunct Professor in Pathology at the Department of Pathology, School of Medicine, University of Utah, USA, Distinguished Professor in Precision Medicine, Binzhou Medical University, Yantai, China and Visiting professor in Molecular Diagnostics and Physiology at Veterinary Medicine and Animal Science, Swedish University of Agricultural Sciences. He is the Director of the Proteomics and Metabolomics platforms at Uppsala University. He is also the Chief Medical Officer and Director of the clinical collaborative research centre in Uppsala – together with Harvard Medical School, Stanford University, Montreal University and Melbourne University – with focus on myalgic encephalomyelitis (ME) and post-viral fatigue.

Professor Bergquist’s group is continuously developing tailored analytical tools for molecular diagnostic screening and discovery of biomarkers of pathological states. Technologies include all important links: identifying relevant clinical applications, invasive in-situ sampling of complex samples, advanced sample pretreatment, multidimensional liquid-based separation, high resolution mass spectrometry and multivariate data analysis. Professor Bergquist among other things focus to explore the neuroimmunological involvement in neurodegenerative diseases by using proteomics and metabolomics with a special interest in cerebrospinal fluid and hard-to-reach tissue studies. Professor Bergquist has currently published over 550 papers, with around 17 500 citations (h-index of 74).